Cepheid

Twenty years ago, the GeneXpert® system entered the clinical market with a bold idea: molecular testing could be faster, simpler and more accessible. We recognize the associates, customers and partners who keep pushing toward better answers and better outcomes. Here’s to the breakthroughs still ahead. #GeneXpert20 #AlwaysOnward #MolecularDiagnostics #Cepheid

Respiratory testing is not one-size-fits-all. In “Goldilocks Diagnostics: Finding the Right Respiratory Test for the Right Patient,” we explore how diagnostic stewardship can help align respiratory testing with the patient, setting, and clinical question. The timing is especially meaningful as Cepheid expands its respiratory testing portfolio with the U.S. launch of the Xpert® Respiratory Panel, a mid-plex option designed to detect 13 respiratory pathogens when broader insight may help inform care. The goal is to choose the approach that is just right for the clinical question in front of you. Read the article: https://lnkd.in/eyEMR9eN?utm_medium=social-organic&utm_source=linkedin&utm_campaign=2026-NAM-CHILD-SOCIAL-BRAND-Insight-Hub&LeadCampaignID=701Nu00000fKYHPIA4 #RespiratoryTesting #DiagnosticStewardship #DiagnosticExcellence #MolecularDiagnostics #Cepheid IVD. In vitro diagnostic medical device. May not be available in all countries

Cepheid began in 1996 with a belief in a better way. Ten years later, the GeneXpert® system entered the clinical market and helped redefine what molecular diagnostics could be. Today, we celebrate 20 years of GeneXpert innovation and the countless clinicians, laboratorians, and healthcare teams who have used fast, simple, and accessible testing to help improve patient care around the world. And we're just getting started. Always onward. https://lnkd.in/eB2XmVCr #GeneXpert20thAnniversary #Cepheid30 #AlwaysOnward #MolecularDiagnostics

Get the latest jobs and industry news

¿Gripe? ¿COVID? ¿Norovirus? Cuando los síntomas se solapan, contar con un diagnóstico preciso es esencial. El sistema GeneXpert® de Cepheid proporciona resultados rápidos mediante PCR, facilitando una toma de decisiones ágil, protegiendo la capacidad asistencial y ayudando a mantener las unidades hospitalarias operativas cuando más se necesita.

Grippe? COVID-19? Norovirus? Wenn sich Symptome überschneiden, ist Klarheit entscheidend. Das GeneXpert® System von Cepheid liefert schnelle PCR-Ergebnisse, unterstützt rasche Entscheidungen, trägt zur Sicherung von Kapazitäten bei und hilft, Stationen offen zu halten, wenn es besonders darauf ankommt. Mehr erfahren: https://lnkd.in/d92ZGQxv